Erratum: Innate IL-17-producing cells: The sentinels of the immune system (Nature Reviews Immunology (2010) 10 (479-489) DOI: 10.1038/nri2800);Innate IL-17-producing cells: The sentinels of the immune system

Nature Reviews Immunology

Volumn 10, Issue 7, 2010, Pages 479-489

  Cua, Daniel J ^a   Tato, Cristina M ^a  

^a MERCK RESEARCH LABORATORIES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; INTERLEUKIN 17;

AUTOIMMUNITY; CD4+ T LYMPHOCYTE; CELL MATURATION; CELL POPULATION; CELL STRESS; CYTOKINE PRODUCTION; HUMAN; IMMUNE RESPONSE; IMMUNOSURVEILLANCE; INFECTION; INNATE IMMUNITY; NATURAL KILLER CELL; NATURAL KILLER T CELL; NEUTROPHIL; PANETH CELL; PATHOGENESIS; PRIORITY JOURNAL; REVIEW; TH17 CELL; TRANSCRIPTION REGULATION;

EID: 77954143695     PISSN: 14741733     EISSN: None     Source Type: Journal    
DOI: 10.1038/nri2819     Document Type: Erratum

References (133)

1. Rouvier, E., Luciani, M. F., Mattei, M. G., Denizot, F. & Golstein, P. CTLA-8, cloned from an activated T cell, bearing AU-rich messenger RNA instability sequences, and homologous to a herpesvirus saimiri gene. J. Immunol. 150, 5445-5456 (1993).
2. Weaver, C. T., Hatton, R. D., Mangan, P. R. & Harrington, L. E. IL-17 family cytokines and the expanding diversity of effector T cell lineages. Annu. Rev. Immunol. 25, 821-852 (2007).
3. Langrish, C. L. et al. IL-23 drives a pathogenic T cell population that induces autoimmune inflammation. J. Exp. Med. 201, 233-240 (2005).
4. +effector T cells develop via a lineage distinct from the T helper type 1 and 2 lineages. Nature Immunol. 6, 1123-1132 (2005).
5. Park, H. et al. A distinct lineage of CD4 T cells regulates tissue inflammation by producing interleukin 17. Nature Immunol. 6, 1133-1141 (2005).
6. Veldhoen, M., Hocking, R. J., Atkins, C. J., Locksley, R. M. & Stockinger, B. TGFβ in the context of an inflammatory cytokine milieu supports de novo differentiation of IL-17-producing T cells. Immunity 24, 179-189 (2006).
7. Wei, L., Laurence, A., Elias, K. M. & O'Shea, J. J. IL-21 is produced by Th17 cells and drives IL-17 production in a STAT3-dependent manner. J. Biol. Chem. 282, 34605-34610 (2007).
8. Zheng, Y. et al. Interleukin-22 mediates early host defense against attaching and effacing bacterial pathogens. Nature Med. 14, 282-289 (2008).
9. H17 cells. Nature 448, 484-487 (2007).
10. + T helper cells. Cell 126, 1121-1133 (2006).
11. Happel, K. I. et al. Cutting edge: roles of Toll-like receptor 4 and IL-2 3 in IL-17 expression in response to Klebsiella pneumoniae infection. J. Immunol. 170, 4432-4436 (2003).
12. Happel, K. I. et al. Divergent roles of IL-23 and IL-12 in host defense against Klebsiella pneumoniae. J. Exp. Med. 202, 761-769 (2005).
13. Ferretti, S., Bonneau, O., Dubois, G. R., Jones, C. E. & Trifilieff, A. IL-17, produced by lymphocytes and neutrophils, is necessary for lipopolysaccharide-induced airway neutrophilia: IL-15 as a possible trigger. J. Immunol. 170, 2106-2112 (2003).
14. Fossiez, F et al. T cell interleukin-17 induces stromal cells to produce proinflammatory and hematopoietic cytokines. J. Exp. Med. 183, 2593-2603 (1996).
15. + CD4-CD8-T cells. J. Interferon Cytokine Res. 16, 611-617 (1996).
16. + T cells. J. Exp. Med. 205, 1381-1393 (2008).
17. Sutton, C. E. et al. Interleukin-1 and IL-23 induce innate IL-17 production from yS T cells, amplifying Th17 responses and autoimmunity. Immunity 31, 331-341 (2009).
18. H17-cell-mediated autoimmunity to environmental toxins. Nature 453, 106-109 (2008).
19. Korn, T., Bettelli, E., Oukka, M. & Kuchroo, V. K. IL-17 and Th17 Cells. Annu. Rev. Immunol. 27, 485-517 (2009).
20. McGeachy, M. J. & Cua, D. J. Th 17 cell differentiation: the long and winding road. Immunity 28, 445-453 (2008).
21. Aggarwal, S., Ghilardi, N., Xie, M. H., de Sauvage, F. J. & Gurney, A. L. Interleukin-23 promotes a distinct CD4 T cell activation state characterized by the production of interleukin-17. J. Biol. Chem. 278, 1910-1914 (2003).
22. Murphy, C. A. et al. Divergent pro-and antiinflammatory roles for IL-2 3 and IL-12 in joint autoimmune inflammation. J. Exp. Med. 198, 1951-1957 (2003).
23. Uhlig, H. H. et al. Differential activity of IL-12 and IL-23 in mucosal and systemic innate immune pathology. Immunity 25, 309-318 (2006).
24. Cua, D. J. et al. Interleukin-23 rather than interleukin-12 is the critical cytokine for autoimmune inflammation of the brain. Nature 421, 744-748 (2003).
25. Aujla, S. J. et al. IL-22 mediates mucosal host defense against Gram-negative bacterial pneumonia. Nature Med. 14, 275-281 (2008).
26. Cella, M. et al. A human natural killer cell subset provides an innate source of IL-22 for mucosal immunity. Nature 457, 722-725 (2009).
27. + lineage distinct from conventional natural killer cells. J. Exp. Med. 207, 281-290 (2010).
28. Takatori, H. et al. Lymphoid tissue inducer-like cells are an innate source of IL-17 and IL-22. J. Exp. Med. 206, 35-41 (2009).
29. Roark, C. L. et al. Exacerbation of collagen-induced arthritis by oligoclonal, IL-17-producing yS T cells. J. Immunol. 179, 5576-5583 (2007).
30. Ito, Y. et al. yS T cells are the predominant source of interleukin-17 in affected joints in collagen-induced arthritis, but not in rheumatoid arthritis. Arthritis Rheum. 60, 2294-2303 (2009).
31. + uveitogenic T cells. J. Immunol. 183, 560-567 (2009).
32. Fenoglio, D. et al. VS1 T lymphocytes producing IFN-y and IL-17 are expanded in HIV-1-infected patients and respond to Candida albicans. Blood 113, 6611-6618 (2009).
33. Aujla, S. J., Dubin, P. J. & Kolls, J. K. Th 17 cells and mucosal host defense. Semin. Immunol. 19, 377-382 (2007).
34. Lockhart, E., Green, A. M. & Flynn, J. L. IL-17 production is dominated by yS T cells rather than CD4 T cells during Mycobacterium tuberculosis infection. J. Immunol. 177, 4662-4669 (2006).
35. Hayday, A. C. yS T cells and the lymphoid stress-surveillance response. Immunity 31, 184-196 (2009).
36. neg iNKT cell population involved in airway neutrophilia. J. Exp. Med. 204, 995-1001 (2007).
37. Passos, S. T et al. IL-6 promotes NK cell production of IL-17 during toxoplasmosis. J. Immunol. 184, 1776-1783 (2010).
38. Jensen, K. D. et al. Thymic selection determines y5 T cell effector fate: antigen-naive cells make interleukin-17 and antigen-experienced cells make interferon y. Immunity 29, 90-100 (2008).
39. Ribot, J. C. et al. CD27 is a thymic determinant of the balance between interferon-y-and interleukin 17-producing yS T cell subsets. Nature Immunol. 10, 427-436 (2009).
40. Haas, J. D. et al. CCR6 and NK 1.1 distinguish between IL-17A and IFN-y-producing yS effector T cells. Eur. J. Immunol. 39, 3488-3497 (2009).
41. + yS T cells as fetal thymus-derived naturally occurring IL-17 producers. J. Immunol. 181, 5940-5947 (2008).
42. Laurence, A. et al. Interleukin-2 signaling via STAT5 constrains T helper 17 cell generation. Immunity 26, 371-381 (2007).
43. Kisielow, J., Kopf, M. & Karjalainen, K. SCART scavenger receptors identify a novel subset of adult y5 T cells. J. Immunol. 181, 1710-1716 (2008).
44. Sun, Z. et al. Requirement for RORy in thymocyte survival and lymphoid organ development. Science 288, 2369-2373 (2000).
45. Eberl, G. et al. An essential function for the nuclear receptor RORyt in the generation of fetal lymphoid tissue inducer cells. Nature Immunol. 5, 64-73 (2004).
46. + cells. Immunity 17, 31-40 (2002).
47. Adachi, S. et al. Essential role of IL-7 receptor a in the formation of Peyer's patch anlage. Int. Immunol. 10, 1-6 (1998).
48. + CD3-cells in the embryonic intestine induces the organizing center of Peyer's patches. Int. Immunol. 11, 643-655 (1999).
49. Meier, D. et al. Ectopic lymphoid-organ development occurs through interleukin 7-mediated enhanced survival of lymphoid-tissue-inducer cells. Immunity 26, 643-654 (2007).
50. + CD3-cells in lymphoid organ development. Immunol. Rev. 189, 41-50 (2002).
51. Cupedo, T & Mebius, R. E. Cellular interactions in lymph node development. J. Immunol. 174, 21-25 (2005).
52. +CD3-cells induce Peyer's patch development: role of a4(31 integrin activation by CXCR5. Immunity 17, 363-373 (2002).
53. Mebius, R. E. Organogenesis of lymphoid tissues. Nature Rev. Immunol. 3, 292-303 (2003).
54. + natural killer-like cells. Nature Immunol. 10, 66-74 (2009).
55. Lane, P. et al. Lymphoid tissue inducer cells in adaptive CD4 T cell dependent responses. Semin. Immunol. 20, 159-163 (2008).
56. + cells that can differentiate to APC NK cells, and follicular cells but not T or B cells. Immunity 7, 493-504 (1997).
57. Kronenberg, M. & Engel, I. On the road: progress in finding the unique pathway of invariant NKT cell differentiation. Curr. Opin. Immunol. 19, 186-193 (2007).
58. Michel, M. L. et al. Critical role of ROR-yt in a new thymic pathway leading to IL-17-producing invariant NKT cell differentiation. Proc. Natl Acad. Sci. USA 105, 19845-19850 (2008).
59. Campillo-Gimenez, L. et al. AIDS progression is associated with the emergence of IL-17-producing cells early after simian immunodeficiency virus infection. J. Immunol. 184, 984-992 (2010).
60. Grajewski, R. S. et al. Activation of invariant NKT cells ameliorates experimental ocular autoimmunity by a mechanism involving innate IFN-y production and dampening of the adaptive Th 1 and Th 17 responses. J. Immunol. 181, 4791-4797 (2008).
61. + cell populations in gut and skin. Nature Immunol. 10, 75-82 (2009).
62. + cell subsets from Id2-dependent precursors. J. Exp. Med. 207, 273-280 (2010).
63. Dhiman, R. et al. IL-22 produced by human NK cells inhibits growth of Mycobacterium tuberculosis by enhancing phagolysosomal fusion. J. Immunol. 183, 6639-6645 (2009).
64. Sanos, S. L. & Diefenbach, A. Isolation of NK cells and NK-like cells from the intestinal lamina propria. Methods Mol. Biol. 612, 505-517 (2010).
65. + cells that provide innate mucosal immune defense. Immunity 29, 958-970 (2008).
66. Satoh-Takayama, N. et al. The natural cytotoxicity receptor NKp46 is dispensable for IL-22-mediated innate intestinal immune defense against Citrobacter rodentium. J. Immunol. 183, 6579-6587 (2009).
67. Ayabe, T. et al. Secretion of microbicidal a-defensins by intestinal Paneth cells in response to bacteria. Nature Immunol. 1, 113-118 (2000).
68. Wilson, C. L. et al. Regulation of intestinal a-defensin activation by the metalloproteinase matrilysin in innate host defense. Science 286, 113-117 (1999).
69. Bultinck, J., Brouckaert, P. & Cauwels, A. The in vivo contribution of hematopoietic cells to systemic TNF and IL-6 production during endotoxemia. Cytokine 36, 160-166 (2006).
70. Keshav, S. et al. Tumor necrosis factor mRNA localized to Paneth cells of normal murine intestinal epithelium by in situ hybridization. J. Exp. Med. 171, 327-332 (1990).
71. Lala, S. et al. Crohn's disease and the NOD2 gene: a role for paneth cells. Gastroenterology 125, 47-57 (2003).
72. Rumio, C. et al. Degranulation of paneth cells via tolllike receptor 9. Am. J. Pathol. 165, 373-381 (2004).
73. Salzman, N. H. et al. Enteric defensins are essential regulators of intestinal microbial ecology. Nature Immunol. 11, 76-83 (2010).
74. Takahashi, N. et al. IL-17 produced by Paneth cells drives TNF-induced shock. J. Exp. Med. 205, 1755-1761 (2008).
75. Li, L. et al. IL-17 produced by neutrophils regulates IFN-γ-mediated neutrophil migration in mouse kidney ischemia-reperfusion injury. J. Clin. Invest. 120, 331-342 (2010).
76. Hoshino, A. et al. MPO-ANCA induces IL-17 production by activated neutrophils in vitro via classical complement pathway-dependent manner. J. Autoimmun. 31, 79-89 (2008).
77. Ivanov, I. I. et al. Induction of intestinal Th17 cells by segmented filamentous bacteria. Cell 139, 485-498 (2009).
78. Ivanov, I. I. & Littman, D. R. Segmented filamentous bacteria take the stage. Mucosal Immunol. 3, 209-212 (2010).
79. Buonocore, S. et al. Innate lymphoid cells drive interleukin-23-dependent innate intestinal pathology. Nature 464, 1371-1375 (2010)
80. Gaffen, S. L. Structure and signalling in the IL-17 receptor family. Nature Rev. Immunol. 9, 556-567 (2009).
81. Tanaka, S. et al. Natural occurring IL-17 producing T cells regulate the initial phase of neutrophil mediated airway responses. J. Immunol. 183, 7523-7530 (2009).
82. Rachitskaya, A. V. et al. Cutting edge: NKT cells constitutively express IL-23 receptor and RORγt and rapidly produce IL-17 upon receptor ligation in an IL-6-independent fashion. J. Immunol. 180, 5167-5171 (2008).
83. He, Y. W., Deftos, M. L., Ojala, E. W. & Bevan, M. J. RORγt, a novel isoform of an orphan receptor, negatively regulates Fas ligand expression and IL-2 production in T cells. Immunity 9, 797-806 (1998).
84. + and respond preferentially under inflammatory conditions. J. Immunol. 183, 2142-2149 (2009).
85. Esser, C., Rannug, A. & Stockinger, B. The aryl hydrocarbon receptor in immunity. Trends Immunol. 30, 447-454 (2009).
86. Schecter, A., Birnbaum, L., Ryan, J. J. & Constable, J. D. Dioxins: an overview. Environ. Res. 101, 419-428 (2006).
87. Rannug, A. et al. Certain photooxidized derivatives of tryptophan bind with very high affinity to the Ah receptor and are likely to be endogenous signal substances. J. Biol. Chem. 262, 15422-15427 (1987).
88. H17 cell differentiation by the aryl hydrocarbon receptor. Nature 453, 65-71 (2008).
89. Martin, B., Hirota, K., Cua, D. J., Stockinger, B. & Veldhoen, M. Interleukin-17-producing γδ T cells selectively expand in response to pathogen products and environmental signals. Immunity 31, 321-330 (2009).
90. Zhou, L. & Littman, D. R. Transcriptional regulatory networks in Th17 cell differentiation. Curr. Opin. Immunol. 21, 146-152 (2009).
91. Kimura, A., Naka, T., Nohara, K., Fujii-Kuriyama, Y. & Kishimoto, T. Aryl hydrocarbon receptor regulates Stat1 activation and participates in the development of Th17 cells. Proc. Natl Acad. Sci. USA 105, 9721-9726 (2008).
92. Duan, J., Chung, H., Troy, E. & Kasper, D. L. Microbial colonization drives expansion of IL-1 receptor 1-expressing and IL-17-producing γ/δ T cells. Cell Host Microbe 7, 140-150 (2010).
93. Yoshiga, Y. et al. Invariant NKT cells produce IL-17 through IL-23-dependent and-independent pathways with potential modulation of Th17 response in collagen-induced arthritis. Int. J. Mol. Med. 22, 369-374 (2008).
94. Riol-Blanco, L. et al. IL-23 receptor regulates unconventional IL-17-producing T cells that control bacterial infections. J. Immunol. 184, 1710-1720 (2010).
95. Curtis, M. M. & Way, S. S. Interleukin-17 in host defence against bacterial, mycobacterial and fungal pathogens. Immunology 126, 177-185 (2009).
96. Iwakura, Y., Nakae, S., Saijo, S. & Ishigame, H. The roles of IL-17A in inflammatory immune responses and host defense against pathogens. Immunol. Rev. 226, 57-79 (2008).
97. Kolls, J. K. & Linden, A. Interleukin-17 family members and inflammation. Immunity 21, 467-476 (2004).
98. Ye, P. et al. Interleukin-17 and lung host defense against Klebsiella pneumoniae infection. Am. J. Respir. Cell. Mol. Biol. 25, 335-340 (2001).
99. Umemura, M. et al. IL-17-mediated regulation of innate and acquired immune response against pulmonary Mycobacterium bovis bacille Calmette-Guerin infection. J. Immunol. 178, 3786-3796 (2007).
100. Peng, M. Y. et al. Interleukin 17-producing γδ T cells increased in patients with active pulmonary tuberculosis. Cell. Mol. Immunol. 5, 203-208 (2008).
101. D'Souza, C. D. et al. An anti-inflammatory role for γδ T lymphocytes in acquired immunity to Mycobacterium tuberculosis. J. Immunol. 158, 1217-1221 (1997).
102. + T cell responses after vaccination and during Mycobacterium tuberculosis challenge. Nature Immunol. 8, 369-377 (2007).
103. Molne, L., Corthay, A., Holmdahl, R. & Tarkowski, A. Role of γ/δ T cell receptor-expressing lymphocytes in cutaneous infection caused by Staphylococcus aureus. Clin. Exp. Immunol. 132, 209-215 (2003).
104. Cho, J. S. et al. IL-17 is essential for host defense against cutaneous Staphylococcus aureus infection in mice. J. Clin. Invest. 120, 1762-1773 (2010).
105. + γδ T cells control early infiltration of neutrophils after Escherichia coli infection via IL-17 production. J. Immunol. 178, 4466-4472 (2007).
106. Siegemund, S. et al. Differential IL-23 requirement for IL-22 and IL-17A production during innate immunity against Salmonella enterica serovar Enteritidis. Int. Immunol. 21, 555-565 (2009).
107. Meeks, K. D., Sieve, A. N., Kolls, J. K., Ghilardi, N. & Berg, R. E. IL-23 is required for protection against systemic infection with Listeria monocytogenes. J. Immunol. 183, 8026-8034 (2009).
108. Kelly, M. N. et al. Interleukin-17/interleukin-17 receptor-mediated signaling is important for generation of an optimal polymorphonuclear response against Toxoplasma gondii infection. Infect. Immun. 73, 617-621 (2005).
109. Chen, Y., Chou, K., Fuchs, E., Havran, W. L. & Boismenu, R. Protection of the intestinal mucosa by intraepithelial γδ T cells. Proc. Natl Acad. Sci. USA 99, 14338-14343 (2002).
110. Kuhl, A. A. et al. Aggravation of intestinal inflammation by depletion/deficiency of γδ T cells in different types of IBD animal models. J. Leukoc. Biol. 81, 168-175 (2007).
111. Kinugasa, T., Sakaguchi, T., Gu, X. & Reinecker, H. C. Claudins regulate the intestinal barrier in response to immune mediators. Gastroenterology 11 8, 1001-1011 (2000).
112. Ogawa, A., Andoh, A., Araki, Y., Bamba, T. & Fujiyama, Y. Neutralization of interleukin-17 aggravates dextran sulfate sodium-induced colitis in mice. Clin. Immunol. 11 0, 55-62 (2004).
113. Liang, S. C. et al. Interleukin (IL)-22 and IL-17 are coexpressed by Th17 cells and cooperatively enhance expression of antimicrobial peptides. J. Exp. Med. 203, 2271-2279 (2006).
114. Chan, Y. R. et al. Lipocalin 2 is required for pulmonary host defense against Klebsiella infection. J. Immunol. 182, 4947-4956 (2009).
115. Ismail, A. S., Behrendt, C. L. & Hooper, L. V. Reciprocal interactions between commensal bacteria and γδ intraepithelial lymphocytes during mucosal injury. J. Immunol. 182, 3047-3054 (2009).
116. Cash, H. L., Whitham, C. V., Behrendt, C. L. & Hooper, L. V. Symbiotic bacteria direct expression of an intestinal bactericidal lectin. Science 313, 1126-1130 (2006).
117. Brandl, K., Plitas, G., Schnabl, B., DeMatteo, R. P. & Pamer, E. G. MyD88-mediated signals induce the bactericidal lectin RegIIIγ and protect mice against intestinal Listeria monocytogenes infection. J. Exp. Med. 204, 1891-1900 (2007).
118. Littman, D. R. & Rudensky, A. Y. Th17 and regulatory T cells in mediating and restraining inflammation. Cell 140, 845-858 (2010).
119. Ely, L. K., Fischer, S. & Garcia, K. C. Structural basis of receptor sharing by interleukin 17 cytokines. Nature Immunol. 10, 1245-1251 (2009).
120. Ishigame, H. et al. Differential roles of interleukin-17A and-17F in host defense against mucoepithelial bacterial infection and allergic responses. Immunity 30, 108-119 (2009).
121. Wucherpfennig, K. W. et al. γδ T-cell receptor repertoire in acute multiple sclerosis lesions. Proc. Natl Acad. Sci. USA 89, 4588-4592 (1992).
122. Shimonkevitz, R., Colburn, C., Burnham, J. A., Murray, R. S. & Kotzin, B. L. Clonal expansions of activated γ/δ T cells in recent-onset multiple sclerosis. Proc. Natl Acad. Sci. USA 90, 923-927 (1993).
123. Kang, Z. et al. Astrocyte-restricted ablation of interleukin-17-induced Act1-mediated signaling ameliorates autoimmune encephalomyelitis. Immunity 32, 414-425 (2010).
124. Duerr, R. H. et al. A genome-wide association study identifies IL23R as an inflammatory bowel disease gene. Science 314, 1461-1463 (2006).
125. Capon, F. et al. Sequence variants in the genes for the interleukin-23 receptor (IL23R) and its ligand (IL12B) confer protection against psoriasis. Hum. Genet. 122, 201-206 (2007).
126. Rueda, B. et al. The IL23R Arg381Gln non-synonymous polymorphism confers susceptibility to ankylosing spondylitis. Ann. Rheum. Dis. 67, 1451-1454 (2008).
127. Griffiths, C. E. et al. Comparison of ustekinumab and etanercept for moderate-to-severe psoriasis. N. Engl. J. Med. 362, 118-128 (2010).
128. H-17 cells in human autoimmune diseases. Nature Immunol. 11, 41-44 (2010).
129. Hurst, S. D. et al. New IL-17 family members promote Th1 or Th2 responses in the lung: in vivo function of the novel cytokine IL-25. J. Immunol. 169, 443-453 (2002).
130. Guo, P. et al. Dual nature of the adaptive immune system in lampreys. Nature 459, 796-801 (2009).
131. Franke, A. et al. Genome-wide association study for ulcerative colitis identifies risk loci at 7q22 and 22q13 (IL17REL). Nature Genet. 42, 292-294 (2010).
132. Fort, M. M. et al. IL-25 induces IL-4, IL-5, and IL-13 and Th2-associated pathologies in vivo. Immunity 15, 985-995 (2001).
133. Colonna, M. Interleukin-22-producing natural killer cells and lymphoid tissue inducer-like cells in mucosal immunity. Immunity 31, 15-23 (2009).